newsfilter
← Latest News
GlobeNewswire·

CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer

BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced the